MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2022 International Congress

    Cross-cultural validation of the Cebuano version of a screening questionnaire for Parkinson’s Disease

    D. Dakay, F. Tangcalagan, E. Villanueva Iii, J. Abejero, G. Saranza (Mandaue City, Philippines)

    Objective: To determine the validity of the Cebuano version of a PD screening questionnaire Background: In the Philippines, actual prevalence of Parkinson’s Disease (PD) is…
  • 2022 International Congress

    Prospective, Multicenter, Real-World Outcomes Study with Directional Deep Brain Stimulation Systems in the Treatment of Parkinson’s Disease

    M. Okun, K. Foote, T. Zesiewicz, Y. Bezchlibnyk, A. Papanastassiou, J. Ramirez-Castaneda, J. Carlson, J. Aldred, V. Krishna, A. Merola, C. Luca, J. Jagid, J. Durphy, L. Verhagen-Metman, S. Sani, S. Ojemann, D. Kern, D. Weintraub, R. Ramdhani, A. Siadati, B. Sundaram, C. Zhao, D. Martinez, M. Siddiqui, S. Tatter, J. Wang, R. Jain (Gainesville, USA)

    Objective: We present preliminary outcomes from an ongoing prospective, on-label, multicenter outcomes study conducted in the United States of patients with directional Deep Brain Stimulation…
  • 2022 International Congress

    Phenotypical and treatment response heterogeneity in a cohort of normal pressure hydrocephalus patients

    A. Di Maio, G. Lazzeri, F. Arienti, F. Ruggiero, F. Mameli, A. Di Fonzo, G. Franco (Milan, Italy)

    Objective: To clinically characterize a cohort of patients with normal pressure hydrocephalus (NPH) to identify possible clinical and humoral biomarkers that can predict the response…
  • 2022 International Congress

    Longitudinal evaluation of hypomimia in individuals with Parkinson’s disease using a video analytics tool

    P. Yang, M. Islam, A. Abdelkader, W. Rahman, M. Pawlik, S. Jensen-Roberts, E. Waddell, T. Myers, J. Soto, E. Hartman, E. Nnadika, R. Wilson, K. Lizarraga, C. Tarolli, R. Schneider, E. Dorsey, J. Adams, E. Hoque (Rochester, USA)

    Objective: To assess hypomimia longitudinally in individuals with Parkinson’s disease (PD) using a video analytics tool. Background: Recent advancements in video analytics - the use…
  • 2022 International Congress

    “Mirror” jaw movements in parkinsonian patients

    V. Kiriakakis, G. Kyriakaki (LAMIA, Greece)

    Objective: To describe synchronous involuntary rhythmic jaw movements during voluntary hand movements in parkinsonian patients. We called them "mirror" jaw movements. Background: Mirror movements (MM)…
  • 2022 International Congress

    Clinicopathologic features of primary lateral sclerosis with TDP-43 presenting as atypical parkinsonism

    A. Murakami, S. Koga, S. Fujioka, K. Bieniek, H. Sekiya, M. Nakamura, Y. Tsuboi, M. Murray, Z. Wszolek, D. Dickson (Jacksonville, USA)

    Objective: To clarify clinicopathologic features of pathologically-confirmed primary lateral sclerosis (PLS). Background: PLS is a neurodegenerative disorder characterized by slowly progressive upper motor neuron signs…
  • 2022 International Congress

    Case report: Parkinsonim with dyskinesia secondary to amyloid angiopathy

    K. Khelfaoui Tredano, G. Berrada, Y. Hsaini, A. Benomar, H. Tibar (Rabat, Morocco)

    Objective: To report a case of parkinsonism secondary to amyloid angiopathy and discuss the pathophysiology and treatment of this entity. Background: Cerebral amyloid angiopathy is…
  • 2022 International Congress

    Burden of COVID-19 among patients with Parkinson’s disease and associated clinical outcomes: Evidence from a meta-analysis

    S. Hussain (Brno, Czech Republic)

    Objective: To understand the burden of covid-19 among patients with Parkinson’s disease and associated clinical outcomes. Background: COVID-19 has affected millions of patients around the…
  • 2022 International Congress

    Capturing the complexity of patients with parkinsonism: Baseline characteristics of participants in the PRIME-UK cross-sectional study

    E. Tenison, D. Pendry-Brazier, M. Smith, F. Lithander, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: This cross-sectional study seeks to describe the symptomatology and health needs of a representative sample of people with parkinsonism, including those living with frailty,…
  • 2022 International Congress

    CSF biomarkers in neurodegenerative parkinsonism can distinguish between multiple system atrophy and 4-repeat tauopathies, but not between disease with Lewy bodies and multiple system atrophy

    P. Kanovsky, K. Bucilova, M. Chudackova, D. Konickova, K. Pekarova, K. Sklenarova, M. Kaiserova, S. Kurcova, M. Nevrly, J. Zapletalova, M. Strnad, K. Mensikova (Olomouc, Czech Republic)

    Objective: To assess the usefulness of a defined set of blood-based and cerebrospinal fluid-based biomarkers in the differential diagnosis of neurodegenerative proteinopathies. Background: The diagnostic…
  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley